SCHEMBL1574030

SCHEMBL1574030

CS(=O)(=O)Nc1ccc(Cc2noc(C3CC4CCC(C3)N4C(=O)O)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTR2C P28335 1/20 0.40
CYP2C19 P33261 1/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.39
GRM5 P41594 1/20 0.35
RIPK1 Q13546 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573931 0.81 KDM4E (0.44) KDM4EHPGDMAPTCYP1A2CYP3A4
SCHEMBL1573928 0.81 KDM4E (0.44) KDM4EHPGDMAPTCYP1A2CYP3A4
SCHEMBL1573882 0.80 CCR5 (0.44)
SCHEMBL1573880 0.80 CCR5 (0.44)
SCHEMBL5635023 0.80 GRM5 (0.36) KDM4EHPGDMAPTCYP1A2CYP3A4
SCHEMBL14514101 0.79 KDM4E (0.46) KDM4EHPGDMAPTCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL5635304 0.78 KDM4E (0.45) KDM4EHPGDMAPTCYP1A2CYP3A4
SCHEMBL7242406 0.77 CCR5 (0.41)
SCHEMBL7242403 0.77 CCR5 (0.41)
SCHEMBL5635025 0.76 GPR119 (0.53) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed